Cargando…

Comprehensive molecular characterization of inhibitors of apoptosis proteins (IAPs) for therapeutic targeting in cancer

BACKGROUND: Inhibitors of apoptosis proteins (IAPs) are a family of antiapoptotic proteins modulating cell cycle, signal transduction and apoptosis. Dysregulated IAPs have been reported to contribute to tumor progression and chemoresistance in various cancers. However, existing studies were sporadic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Jianfeng, Zhao, Wanni, Tong, Pan, Li, Ping, Zhao, Yuanli, Li, Hua, Liang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975060/ https://www.ncbi.nlm.nih.gov/pubmed/31964418 http://dx.doi.org/10.1186/s12920-020-0661-x

Ejemplares similares

An expression based REST signature predicts patient survival and therapeutic response for glioblastoma multiforme
por: Liang, Jianfeng, et al.
Publicado: (2016)

Molecular and Functional Characterization of Inhibitor of Apoptosis Proteins (IAP, BIRP) in Echinococcus granulosus
por: Zhan, Jiafei, et al.
Publicado: (2020)

Regulation of Apoptosis by Inhibitors of Apoptosis (IAPs)
por: Berthelet, Jean, et al.
Publicado: (2013)

Inhibitor of Apoptosis Proteins (IAPs) as therapeutic targets in Multiple Myeloma (MM)
por: Ramakrishnan, Vijay, et al.
Publicado: (2014)

Molecular characterization of an inhibitor of apoptosis protein (IAPs) in freshwater pearl mussel, Hyriopsis schlegelii
por: Wu, Di, et al.
Publicado: (2019)

Inhibitor of Apoptosis (IAP) proteins as drug targets for the treatment of cancer
por: Vaux, David L
Publicado: (2009)

Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs
por: Verhagen, Anne M, et al.
Publicado: (2001)

The Inhibitor of Apoptosis (IAPs) in Adaptive Response to Cellular Stress
por: Marivin, Arthur, et al.
Publicado: (2012)

Targeting the BIR Domains of Inhibitor of Apoptosis (IAP) Proteins in Cancer Treatment
por: Cossu, Federica, et al.
Publicado: (2019)

Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)
por: Rathore, Rama, et al.
Publicado: (2017)

IAPs on the move: role of inhibitors of apoptosis proteins in cell migration
por: Oberoi-Khanuja, T K, et al.
Publicado: (2013)

Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist
por: Udompholkul, Parima, et al.
Publicado: (2023)

IAP-IAP Complexes Required for Apoptosis Resistance of C. trachomatis–Infected Cells
por: Rajalingam, Krishnaraj, et al.
Publicado: (2006)

Next-Generation Sequencing Analysis of ctDNA for the Detection of Glioma and Metastatic Brain Tumors in Adults
por: Liang, Jianfeng, et al.
Publicado: (2020)

Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells
por: Friboulet, Luc, et al.
Publicado: (2010)

A Giant Ubiquitin-conjugating Enzyme Related to IAP Apoptosis Inhibitors
por: Hauser, Hans-Peter, et al.
Publicado: (1998)

Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma
por: Augello, Claudia, et al.
Publicado: (2009)

The REST Gene Signature Predicts Drug Sensitivity in Neuroblastoma Cell Lines and Is Significantly Associated with Neuroblastoma Tumor Stage
por: Liang, Jianfeng, et al.
Publicado: (2014)

Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarization
por: Morón-Calvente, Virginia, et al.
Publicado: (2018)

Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma
por: Zhou, Jun, et al.
Publicado: (2011)

Impact of Group II Baculovirus IAPs on Virus-Induced Apoptosis in Insect Cells
por: Zheng, Hao, et al.
Publicado: (2022)

Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression
por: Paschall, Amy V, et al.
Publicado: (2014)

BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors
por: Cremona, Mattia, et al.
Publicado: (2022)

LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC
por: Yang, Chengcheng, et al.
Publicado: (2016)

Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2
por: Darding, M, et al.
Publicado: (2011)

Tumors Acquire Inhibitor of Apoptosis Protein (IAP)-mediated Apoptosis Resistance through Altered Specificity of Cytosolic Proteolysis
por: Hong, Xu, et al.
Publicado: (2003)

Analysis of circRNA‐mRNA expression profiles and functional enrichment in diabetes mellitus based on high throughput sequencing
por: Zhao, Wanni, et al.
Publicado: (2022)

Development of Peptidomimetics Targeting IAPs
por: Sharma, Sushil K., et al.
Publicado: (2006)

IAP Workshop
Publicado: (1996)

Inhibitor of Apoptosis Proteins (IAPs) are commonly dysregulated in GIST and can be pharmacologically targeted to enhance the pro-apoptotic activity of imatinib
por: Falkenhorst, Johanna, et al.
Publicado: (2016)

Targeted ablation of the cellular inhibitor of apoptosis 1 (cIAP1) attenuates denervation-induced skeletal muscle atrophy
por: Lala-Tabbert, Neena, et al.
Publicado: (2019)

Cellular inhibitor of apoptosis 2 (cIAP2) restricts neuroinflammation during experimental autoimmune encephalomyelitis
por: Biswas, Debolina D., et al.
Publicado: (2022)

IAP inhibitors enhance co-stimulation to promote tumor immunity
por: Dougan, Michael, et al.
Publicado: (2010)

Effects of Physiological and Synthetic IAP Antagonism on c-IAP-Dependent Signaling
por: Kocab, Andrew J., et al.
Publicado: (2015)

Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents
por: Wang, Chao, et al.
Publicado: (2022)

Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity
por: Yuan, Z, et al.
Publicado: (2013)

Targeting IAP proteins in combination with radiotherapy
por: Fulda, Simone
Publicado: (2015)

RANKL enhances the effect of an antagonist of inhibitor of apoptosis proteins (cIAPs) in RANK-positive breast cancer cells
por: Casimiro, S., et al.
Publicado: (2013)

Mechanisms of cisplatin-induced cell death in malignant mesothelioma cells: Role of inhibitor of apoptosis proteins (IAPs) and caspases
por: CREGAN, INEZ L., et al.
Publicado: (2012)

Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients
por: Khan, Salma, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_giseen9h3mf5v54vvub8j2rl7a